Michael, MR, Wieske, L, Allen, JA, Lunn, MP, Doppler, K, Tan, CY, Koike, H, Markvardsen, LK, Kapoor, M, Hsieh, ST, Nobile-Orazio, E, Jacobs, BC, Rajabally, YA, Basta, I, Ripellino, P, Querol, L, Eftimov, F. Inflammatory Neuropathy Consortium base (INCbase): a protocol of a global prospective observational cohort study for the development of a prediction model for treatment response in chronic inflammatory demyelinating polyneuropathy. BMC Neurology. 2024; 24(1)DOI:10.1186/s12883-024-03903-w. PMID:39455929. IF:2.200(Q3/6D).

Monceau, A, Nath, RG, Suárez-Calvet, X, Musumeci, O, Toscano, A, Kierdaszuk, B, Kostera-Pruszczyk, A, Domínguez-González, C, Hernández-Lain, A, Paradas, C, Rivas, E, Papadimas, G, Papadopoulos, C, Chrysanthou-Piterou, M, Gallardo, E, Olivé, M, Lilleker, J, Roberts, ME, Marchese, D, Lunazzi, G, Heyn, H, Fernández-Simón, E, Villalobos, E, Clark, J, Katsikis, P, Collins, C, Mehra, P, Laidler, Z, Vincent, A, Tasca, G, Marini-Bettolo, C, Guglieri, M, Straub, V, Raben, N, Díaz-Manera, J. Decoding the muscle transcriptome of patients with late-onset Pompe disease reveals markers of disease progression. BRAIN. 2024; DOI:10.1093/brain/awae249. PMID:39045638. IF:11.700(Q1/1D).

Saposnik, G, Monreal, E, Medrano, N, García-Domínguez, JM, Querol, L, Meca-Lallana, JE, Landete, L, Salas, E, Meca-Lallana, V, García-Arcelay, E, Agüera-Morales, E, Martínez-Yélamos, S, Gómez-Ballesteros, R, Maurino, J, Villar, LM, Caminero, AB. Does serum neurofilament light chain measurement influence therapeutic decisions in multiple sclerosis?. Multiple Sclerosis and Related Disorders. 2024; 90DOI:10.1016/j.msard.2024.105838. PMID:39216454. IF:2.900(Q2/4D).

Allen, JA, Lin, J, Basta, I, Dysgaard, T, Eggers, C, Guptill, J, Gwathmey, KG, Hewamadduma, C, Hofman, E, Hussain, YM, Kuwabara, S, Le Masson, G, Leypoldt, F, Chang, T, Lipowska, M, Lowe, M, Lauria, G, Querol, L, Simu, MA, Suresh, N, Tse, A, Ulrichts, P, Van Hoorick, B, Yamasaki, R, Lewis, RA, van Doorn, PA. Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE) : a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial. LANCET NEUROLOGY. 2024; 23(10)DOI:10.1016/S1474-4422(24)00309-0. PMID:39304241. IF:45.500(Q1/1D).

Bolano-Díaz, C, Verdú-Díaz, J, Díaz-Manera, J. MRI for the diagnosis of limb girdle muscular dystrophies. CURRENT OPINION IN NEUROLOGY. 2024; 37(5)DOI:10.1097/WCO.0000000000001305. PMID:39132784. IF:4.400(Q1/2D).

Llansó, L, Segarra-Casas, A, Domínguez-González, C, Malfatti, E, Kapetanovic, S, Rodríguez-Santiago, B, de la Calle, O, Blanco, R, Dobrescu, A, Nascimento-Osorio, A, Paipa, A, Hernandez-Lain, A, Jou, C, Mariscal, A, González-Mera, L, Arteche, A, Lleixa, C, Caballero-Avila, M, Carbayo, A, Vesperinas, A, Querol, L, Gallardo, E, Olivé, M. Absence of Pathogenic Mutations and Strong Association With HLA-DRB1*11:01 in Statin-Naïve Early-Onset Anti-HMGCR Necrotizing Myopathy. Neurology-Neuroimmunology & Neuroinflammation. 2024; 11(5)DOI:10.1212/NXI.0000000000200285. PMID:39106428. IF:7.500(Q1/1D).

Cortes-Vicente, E, Borsi, AJ, Gary, C, Noel, WGJ, Lee, JMS, Karmous, W, Zhang, QY, Gandhi, KH, Batista, AE, Decourcy, JJ, Barlow, SG, Birija, SL, Gibson, GA. The impact of diagnosis delay on European patients with generalised myasthenia gravis. Annals of Clinical and Translational Neurology. 2024; 11(9)DOI:10.1002/acn3.52122. PMID:39090840. IF:3.900(Q1/3D).

Pascual-Goñi, E, Martín-Aguilar, L, Lleixà, C, Mariscal, A, Tejada-Illa, C, Caballero-Avila, M, Martinez-Hernandez, E, Serfim, A, Moga, E, Rojas-García, R, López-Pardo, J, Novelli, S, Gallardo, E, Sabater, L, Querol, L. ANTI-HNK-1 IGM AND SNFL LEVELS ARE POTENTIAL BIOMARKERS FOR MONITORING DISEASE ACTIVITY IN ANTI-MAG NEUROPATHY. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).

Collet-Vidiella, R, Mederer-Fernandez, T, Caballero-Avila, M, Tejada-Illa, C, Pascual-Goñi, E, Martín-Aguilar, L, Lleixà, C, Querol, L. ANTI-CASPR1 AUTOIMMUNE NODOPATHY AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).

Lleixà, C, Martínez-Martínez, L, Pascual-Goñi, E, Martín-Aguilar, L, Caballero-Avila, M, Collet, R, Illa, CT, Gallardo, E, Boera-Carnicero, G, Calahorro, V, Martín, OD, Callegari, I, Cortese, A, Delmont, E, Devaux, J, Giannotta, C, Nobie-Orazio, E, Höftberger, R, Herdewyn, S, Carvajal, A, Torné, L, Jericó-Pascual, I, Querol, L. ANTI-CASPR1 ANTIBODIES ARE ASSOCIATED WITH HLA-DRB1*03:01 ALLELES. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).

Querol, L, Borsi, A, Gary, C, Noel, W, Karmous, W, DeCourcy, J, Wright, J, Taylor, Y, Iqbal, H, Rinaldi, S. CHARACTERISTICS OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY SUBTYPES: RESULTS FROM A MULTINATIONAL, REAL-WORLD SURVEY. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).

Illa, CT, Pegueroles, J, Claramunt-Molet, M, Pi-Cervera, A, Heras-Delgado, A, Gascón-Fontal, J, Idelsohn-Zielonka, S, Vidal, N, Martín-Aguilar, L, Caballero-Avila, M, Lleixà, C, Llansó, L, Rojas-García, R, Querol, L, Pascual-Goñi, E. LONGITUDINAL GAIT ASSESSMENT USING A WEARABLE SYSTEM DETECTS CLINICALLY SIGNIFICANT CHANGES IN PATIENTS WITH PERIPHERAL NEUROPATHIES. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).

van der Pol, WL, Peric, S, Querol, L, Hussain, Y, Cadour, S, Van de Walle, I, Persson, E, Van Hoomissen, I, Mashchenko, O, Vujcic, M, Van de Steen, O, Allen, JA. EMPASIPRUBART (ARGX-117) IN MULTIFOCAL MOTOR NEUROPATHY: INITIAL SAFETY AND EFFICACY DATA OF THE PHASE 2 ARDA STUDY. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).

Martín-Aguilar, L, Collet, R, Lleixà, C, Caballero-Avila, M, Tejada-Illa, C, Pascual-Goñi, E, Sedano-Tous, MJ, Casasnovas, C, Gutiérrez-Gutiérrez, G, Pardo-Fernández, J, Rojas, R, Turón, J, Gallardo, E, Cortés-Vicente, E, Llansó, L, García, JM, Farrés, J, Querol, L. SERUM PROTEOME IN GUILLAIN-BARRE SYNDROME USING AN APTAMER-BASED PROTEOMICS PLATFORM. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).

Caballero-Avila, M, Martín-Aguilar, L, Pascual-Goñi, E, Tejada-Illa, C, Collet, R, Rojas-García, R, Gallardo, E, Martínez-Martínez, L, Doneddu, P, Nobile-Orazio, E, de Winter, J, Alonso-Jimenez, A, del Real, MA, Armangué, T, Delmont, E, Xuclà-Ferrarons, T, Roche, JC, Jauregui, A, González, A, Ortiz, N, Liong, HF, de Rivera, FJR, Sparasci, D, Ripellino, P, Pérez-Pérez, H, Guerrero-Sola, A, Vegezzi, E, Baars, A, Jacobs, B, Wieske, L, Eftimov, F, Lleixà, C, Querol, L. CLINICAL AND IMMUNOLOGICAL RELAPSES ARE INFREQUENT IN PATIENTS WITH ANTI-CNTN1 AUTOIMMUNE NODOPATHY. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).

Lewis, RA, Allen, J, Merkies, ISJ, van Doorn, PA, Sommer, C, Wallstroem, E, Luo, XD, Alonso-Alonso, M, Atassi, N, Querol, L. PHASE 3 TRIAL DESIGNS EVALUATING RILIPRUBART, A C1S-COMPLEMENT INHIBITOR, IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).

Querol, L, Lewis, RA, Hartung, HP, Van Doorn, PA, Wallstroem, E, Auwarter, K, Luo, XD, Alonso-Alonso, M, Atassi, N, Hughes, RAC. PHASE 2 EFFICACY AND SAFETY OF RILIPRUBART, A C1S-COMPLEMENT INHIBITOR, IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).

Van Doorn, PA, Querol, L, Hartung, HP, Hughes, RAC, Orsini, M, Hakimi-Hawken, N, Minor, C, Msihid, J, Alonso-Alonso, M, Atassi, N, Lewis, R. PHASE 2 TRIAL OF RILIPRUBART IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: QUALITY-OF-LIFE AND FATIGUE. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).

Querol, L, Lewis, RA, Van Doorn, PA, Hughes, RAC, Storek, M, Rajagopal, V, Chow, T, Luo, XD, Alonso-Alonso, M, Atassi, N, Hartung, HP. PHASE 2 TRIAL OF RILIPRUBART IN CIDP: EFFECT ON COMPLEMENT BIOMARKERS AND NEUROFILAMENT LIGHT CHAIN. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).

Fernandez-Eulate, G, Gitiaux, C, Thiele, S, Jungbluth, H, Audic, F, Potulska-Chromik, A, Marini-Bettolo, C, Davion, JB, de la Tassa, GM, Olivé, M, de la Hoz, CPDF, Isapof, A, Töpf, A, Walter, M, Angelini, C, Claeys, K, Kostera-Pruszczyk, A, Attarian, S, Straub, V, Domínguez-González, C, Vissing, J, Metay, C, Khraiche, D, Wahbi, K, Stojkovic, T. CLINICAL AND GENETIC SPECTRUM OF PATIENTS WITH BAG3-RELATED NEUROMUSCULAR DISORDERS IN EUROPE. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).

Michael, M, Wieske, L, Allen, J, Lunn, M, Doppler, K, Tan, CY, Koike, H, Markvardsen, L, Kapoor, M, Hsieh, ST, Nobie-Orazio, E, Jacobs, B, Rajabally, Y, Basta, I, Ripellino, P, Querol, L, Eftimov, F. TREATMENT RESPONSE AND REFRACTORINESS IN PATIENTS WITH CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (INCBASE). JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).

Hamadeh, T, van de Mortel, J, Van Doormaal, P, Cornblath, D, Vrancken, AFJE, Faber, C, Goedee, S, Minnema, M, Thomas, S, Khoshnoodi, M, Lunn, M, Keddie, S, Carr, A, D'Sa, S, Mair, D, Querol, L, Pascual-Goñi, E, Illa, CT, Harbo, T, Orazio, EN, Cutellè, C, Bianco, M, Svahn, J, Merle, H, Karlin, L, Echaniz-Laguna, A, Cauquil, C, Labeyrie, C, Peric, S, Basta, I, Palibrk, A, Stinoc, A, Briani, C, Salvalaggio, A, Marasca, M, Van den Bergh, P, Dubuisson, N, Marques, W Jr, Nascimento, O, Elsheikh, B, Doughty, C, Attarian, S, Delmont, E, Rausch, HW, Schirmer, L, Notermans, NC, Merkies, ISJ. RASCH-BUILT ATAXIA RATING SALE FOR IGM-ASSOCIATED POLYNEUROPATHY WITH AND WITHOUT ANTI-MAG ANTIBODIES (IGM-PNP RB-ARS). JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).

Doneddu, P, Asselta, R, Manganelli, F, Cocito, D, Inghilleri, M, Ricciardi, D, Cavaletti, G, Di Stefano, V, Filosto, M, Carta, A, Vegezzi, E, Matà, S, Habetswallner, F, Farotti, L, Luigetti, M, Ruiu, E, Mataluni, G, Falzone, Y, Carpo, M, Leonardi, L, Gentile, L, Ripellino, P, Peric, S, Basta, I, Querol, L, Jacobs, B, Eftimov, F, Orazio, EN. DISSECTING THE GENETIC ARCHITECTURE OF CIDP. STUDY PROTOCOL FOR AN INTERNATIONAL COLLABORATIVE GENOME-WIDE ASSOCIATION STUDY. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).

Allen, J, Van Doorn, PA, Basta, I, Dysgaard, T, Eggers, C, Guptill, J, Gwathmey, K, Hewamadduma, C, Hofman, E, Hussain, Y, Kuwabara, S, Le Masson, G, Leypoldt, F, Lin, J, Lipowska, M, Lowe, M, Pinter, GL, Querol, L, Simu, MA, Chang, T, Tse, A, Ulrichts, P, Van Hoorick, B, Yamasaki, R, Lewis, RA. EFFICACY AND SAFETY OF SUBCUTANEOUS (SC) EFGARTIGIMOD PH20 IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: ADHERE/ADHERE plus TRIALS. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).

Martínez-Martínez, L, Lacruz, AC, Querol, L, Cortés-Vicente, E, Pascual, E, Rojas-García, R, Reyes-Leiva, D, Alvaro, Y, Moltó, E, Ortiz, E, Gallardo, E, Juárez, C, Mariscal, A. Inter-laboratory comparison of routine autoantibody detection methods for autoimmune neuropathies and myasthenia gravis. JOURNAL OF NEUROLOGY. 2024; 271(7)DOI:10.1007/s00415-024-12317-0. PMID:38578496. IF:4.600(Q1/2D).

Cortés-Vicente, E, Schreiner, B, Saccà, F, Narayanaswami, P. Editorial: New perspectives in the treatment of myasthenia gravis. Frontiers in Neurology. 2024; 15DOI:10.3389/fneur.2024.1418631. PMID:38919972. IF:2.800(Q2/5D).

Saccà, F, Salort-Campana, E, Jacob, S, Cortés-Vicente, E, Schneider-Gold, C. Refocusing generalized myasthenia gravis: Patient burden, disease profiles, and the role of evolving therapy. EUROPEAN JOURNAL OF NEUROLOGY. 2024; 31(6)DOI:10.1111/ene.16180. PMID:38117543. IF:3.900(Q1/3D).

Tawil, R, Wagner, KR, Hamel, J, Leung, DG, Statland, JM, Wang, LH, Genge, A, Sacconi, S, Lochmüller, H, Reyes-Leiva, D, Diaz-Manera, J, Alonso-Perez, J, Muelas, N, Vilchez, JJ, Pestronk, A, Gibson, S, Goyal, NA, Hayward, LJ, Johnson, N, LoRusso, S, Freimer, M, Shieh, PB, Subramony, SH, van Engelen, B, Kools, J, Leinhard, OD, Widholm, P, Morabito, C, Moxham, CM, Cadavid, D, Mellion, ML, Odueyungbo, A, Tracewell, WG, Accorsi, A, Ronco, L, Gould, RJ, Shoskes, J, Rojas, LA, Jiang, JG. Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial. LANCET NEUROLOGY. 2024; 23(5)DOI:10.1016/S1474-4422(24)00073-5. PMID:38631764. IF:45.500(Q1/1D).

Piñol-Jurado, P, Verdú-Díaz, J, Fernández-Simón, E, Domínguez-González, C, Hernández-Lain, A, Lawless, C, Vincent, A, González-Chamorro, A, Villalobos, E, Monceau, A, Laidler, Z, Mehra, P, Clark, J, Filby, A, Mcdonald, D, Rushton, P, Bowey, A, Perez, JA, Tasca, G, Marini-Bettolo, C, Guglieri, M, Straub, V, Suarez-Calvet, X, Diaz-Manera, J. Imaging mass cytometry analysis of Becker muscular dystrophy muscle samples reveals different stages of muscle degeneration. Scientific Reports. 2024; 14(1)DOI:10.1038/s41598-024-51906-x. PMID:38336890. IF:3.900(Q1/2D).

Pascual-Goñi, E, Collet, R, Tejada-Illa, C, Martín-Aguilar, L, Caballero-Avila, M, Lleixà, C, Novelli, S, López-Pardo, J, Sanfeliu, AE, Mariscal, A, Gargallo, YA, Martínez-Hernández, E, Cocho, D, Querol, L. Excellent response to anti-CD38 therapy with daratumumab in a patient with severe refractory CANOMAD. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2024; 95(7)DOI:10.1136/jnnp-2023-332443. PMID:38341197. IF:7.500(Q1/1D).

Bolano-Diaz, C, Verdú-Díaz, J, Gonzalez-Chamorro, A, Fitzsimmons, S, Veeranki, G, Straub, V, Diaz-Manera, J. Magnetic resonance imaging-based criteria to differentiate dysferlinopathy from other genetic muscle diseases. NEUROMUSCULAR DISORDERS. 2024; 34DOI:10.1016/j.nmd.2023.11.004. PMID:38007344. IF:2.800(Q2/5D).

Esteller D., Schiava M., Verdú-Díaz J., Villar-Quiles R.-N., Dibowski B., Venturelli N., Laforet P., Alonso-Pérez J., Olive M., Domínguez-González C., Paradas C., Vélez B., Kostera-Pruszczyk A., Kierdaszuk B., Rodolico C., Claeys K., Pál E., Malfatti E., Souvannanorath S., Alonso-Jiménez A., de Ridder W., De Smet E., Papadimas G., Papadopoulos C., Xirou S., Luo S., Muelas N., Vilchez J.J., Ramos-Fransi A., Monforte M., Tasca G., Udd B., Palmio J., Sri S., Krause S., Schoser B., Fernández-Torrón R., López de Munain A., Pegoraro E., Farrugia M.E., Vorgerd M., Manousakis G., Chanson J.B., Nadaj-Pakleza A., Cetin H., Badrising U., Warman-Chardon J., Bevilacqua J., Earle N., Campero M., Díaz J., Ikenaga C., Lloyd T.E., Nishino I., Nishimori Y., Saito Y., Oya Y., Takahashi Y., Nishikawa A., Sasaki R., Marini-Bettolo C., Guglieri M., Straub V., Stojkovic T., Carlier R.Y., Díaz-Manera J.. Correction to: Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP-mediated disease reveals characteristic features useful for diagnosis (Journal of Neurology, (2023), 270, 12, (5849-5865), 10.1007/s00415-023-11862-4). JOURNAL OF NEUROLOGY. 2024; 271(4)DOI:10.1007/s00415-023-12178-z. PMID:38349561. IF:4.600(Q1/2D).

Fonseca, E, Cabrera-Maqueda, JM, Ruiz-Garcia, R, Naranjo, L, Diaz-Pedroche, C, Velasco, R, Macias-Gomez, A, Milisenda, JC, Munoz-Farjas, E, Pascual-Goni, E, Perez-Larraya, JG, Saiz, A, Dalmau, J, Blanco, Y, Graus, F, Martinez-Hernandez, E. Neurological adverse events related to immune-checkpoint inhibitors in Spain: a retrospective cohort study. LANCET NEUROLOGY. 2023; 22(12)DOI:10.1016/S1474-4422(23)00335-6. PMID:37977714. IF:46.600(Q1/1D).

Bermejo-Guerrero, L, Fernández-de la Hoz, CPD, González-Quereda, L, Segarra-Casas, A, Nedkova, V, Gallano, P, Martín-Jiménez, P, Hernández-Laín, A, Olivé, M, Arteche-López, A, Domínguez-González, C. Distal myopathy due to digenic inheritance of TIA1 and SQSTM1 variants in two unrelated Spanish patients. NEUROMUSCULAR DISORDERS. 2023; 33(12)DOI:10.1016/j.nmd.2023.10.016. PMID:38016875. IF:2.700(Q2/4D).

Liberatore, G, De Lorenzo, A, Giannotta, C, Manganelli, F, Filosto, M, Cosentino, G, Cocito, D, Briani, C, Cortese, A, Fazio, R, Lauria, G, Clerici, AM, Rosso, T, Marfia, GA, Antonini, G, Cavaletti, G, Carpo, M, Doneddu, PE, Spina, E, Piccinelli, SC, Peci, E, Querol, L, Nobile-Orazio, E. Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian database (vol 43, pg 3939, 2022). NEUROLOGICAL SCIENCES. 2023; DOI:10.1007/s10072-023-07184-y. PMID:38008812. IF:2.700(Q2/4D).

Broers, MC, Wieske, L, Erdag, E, Gürlek, C, Bunschoten, C, van Doorn, PA, Eftimov, F, Kuitwaard, K, de Vries, JM, de Wit, MCY, Nagtzaam, MMP, Franken, SC, Zhu, LIS, Paunovic, M, de Wit, M, Schreurs, MWJ, Lleixà, C, Martín-Aguilar, L, Pascual-Goñi, E, Querol, L, Jacobs, BC, Huizinga, R, Titulaer, MJ. Clinical relevance of distinguishing autoimmune nodopathies from CIDP: longitudinal assessment in a large cohort. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2023; 95(1)DOI:10.1136/jnnp-2023-331378. PMID:37879898. IF:8.800(Q1/1D).

Meca-Lallana J.E., Prieto González J.M., Caminero Rodríguez A.B., Olascoaga Urtaza J., Alonso A.M., Durán Ferreras E., Espinosa R., Dotor J., Romera M., Ares Luque A., Pérez Ruiz D., Calles C., Hernández M.A., Hervás García M., Mendoza Rodríguez A., Berdei Montero Y., Téllez N., Herrera Varó N., Sotoca J., Presas-Rodríguez S., Querol Gutierrez L.A., Hervás Pujol M., Batlle Nadal J., Martín Ozaeta G., Gubieras Lillo L., Martínez Yélamos S., Ramió-Torrentà L., Mallada Frechin J., Belenguer Benavides A., Gascón-Giménez F., Casanova B., Landete Pascual L., Berenguer L., Navarro L., Gómez Gutierrez M., Durán C., Rodríguez Regal A., Álvarez E., García-Estévez D.A., López Real A.M., Llaneza González M.A., Marzo Sola M.E., Sánchez-Menoyo J.L., Oterino A., Villaverde González R., Castillo-Triviño T., Álvarez de Arcaya A., Llarena C.. Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study. Neurology and Therapy. 2023; 12(6)DOI:10.1007/s40120-023-00557-7. PMID:37861931. IF:4.000(Q1/2D).

van Doorn P.A., Van den Bergh P.Y.K., Hadden R.D.M., Avau B., Vankrunkelsven P., Attarian S., Blomkwist-Markens P.H., Cornblath D.R., Goedee H.S., Harbo T., Jacobs B.C., Kusunoki S., Lehmann H.C., Lewis R.A., Lunn M.P., Nobile-Orazio E., Querol L., Rajabally Y.A., Umapathi T., Topaloglu H.A., Willison H.J.. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndrome. EUROPEAN JOURNAL OF NEUROLOGY. 2023; 30(12)DOI:10.1111/ene.16073. PMID:37814552. IF:4.500(Q1/2D).

van Doorn P.A., Van den Bergh P.Y.K., Hadden R.D.M., Avau B., Vankrunkelsven P., Attarian S., Blomkwist-Markens P.H., Cornblath D.R., Goedee H.S., Harbo T., Jacobs B.C., Kusunoki S., Lehmann H.C., Lewis R.A., Lunn M.P., Nobile-Orazio E., Querol L., Rajabally Y.A., Umapathi T., Topaloglu H.A., Willison H.J.. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndrome. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2023; 28(4)DOI:10.1111/jns.12594. PMID:37814551. IF:4.000(Q1/2D).

Esteller D., Schiava M., Villar-Quiles, RN, Dibowski B., Venturelli N., Laforet P., Alonso-Pérez J., Olive M., Domínguez-González C., Paradas C., Vélez B., Kostera-Pruszczyk A., Kierdaszuk B., Rodolico C., Claeys K., Pál E., Malfatti E., Souvannanorath S., Alonso-Jiménez A., de Ridder W., De Smet E., Papadimas G., Papadopoulos C., Xirou S., Luo S., Muelas N., Vilchez J.J., Ramos-Fransi A., Monforte M., Tasca G., Udd B., Palmio J., Sri S., Krause S., Schoser, B, Fernández-Torrón R., de Munain, AL, Pegoraro E., Farrugia M.E., Vorgerd M., Manousakis G., Chanson J.B., Nadaj-Pakleza A., Cetin H., Badrising U., Warman-Chardon J., Bevilacqua J., Earle N., Campero M., Díaz J., Ikenaga C., Lloyd T.E., Nishino I., Nishimori Y., Saito Y., Oya Y., Takahashi Y., Nishikawa A., Sasaki R., Marini-Bettolo C., Guglieri M., Straub V., Stojkovic T., Carlier R.Y., Díaz-Manera J.. Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP-mediated disease reveals characteristic features useful for diagnosis. JOURNAL OF NEUROLOGY. 2023; 270(12)DOI:10.1007/s00415-023-11862-4. PMID:37603075. IF:4.800(Q1/2D).